--- title: "12 Health Care Stocks Moving In Thursday's After-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/287974640.md" description: "In Thursday's after-market session, Tyr Pharma (NASDAQ:ATYR) shares surged 21.0% to $0.59, while Artiva Biotherapeutics (NASDAQ:ARTV) rose 10.77% to $8.43. IM Cannabis (NASDAQ:IMCC) increased by 8.77% to $0.32. Conversely, NewGenIvf Group (NASDAQ:NIVF) fell 9.7% to $0.93, and Outlook Therapeutics (NASDAQ:OTLK) dropped 6.98% to $0.69." datetime: "2026-05-28T21:05:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287974640.md) - [en](https://longbridge.com/en/news/287974640.md) - [zh-HK](https://longbridge.com/zh-HK/news/287974640.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Thursday's After-Market Session ### Gainers - **aTyr Pharma** (NASDAQ:ATYR) shares rose 21.0% to $0.59 during Thursday's after-market session. The market value of their outstanding shares is at $46.8 million. - **Artiva Biotherapeutics** (NASDAQ:ARTV) shares rose 10.77% to $8.43. The company's market cap stands at $370.7 million. - **IM Cannabis** (NASDAQ:IMCC) shares increased by 8.77% to $0.32. The company's market cap stands at $1.5 million. - **Agape ATP** (NASDAQ:ATPC) stock increased by 7.57% to $6.53. The market value of their outstanding shares is at $2.8 million. - **MAIA Biotechnology** (AMEX:MAIA) shares rose 6.97% to $1.38. The company's market cap stands at $79.6 million. - **SciSparc** (NASDAQ:SPRC) stock rose 6.62% to $11.25. The company's market cap stands at $2.4 million. ### Losers - **NewGenIvf Group** (NASDAQ:NIVF) stock fell 9.7% to $0.93 during Thursday's after-market session. - **Outlook Therapeutics** (NASDAQ:OTLK) shares fell 6.98% to $0.69. The market value of their outstanding shares is at $70.7 million. - **BioRestorative Therapies** (NASDAQ:BRTX) stock fell 6.56% to $0.45. The market value of their outstanding shares is at $11.0 million. - **Jupiter Neurosciences** (NASDAQ:JUNS) shares declined by 5.95% to $0.27. The market value of their outstanding shares is at $10.4 million. - **QTREX Quantum** (NASDAQ:QTEX) stock fell 5.67% to $2.83. The company's market cap stands at $91.5 million. - **Aspire Biopharma Holdings** (NASDAQ:ASBP) stock declined by 5.61% to $5.22. The company's market cap stands at $6.0 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [ARTV.US](https://longbridge.com/en/quote/ARTV.US.md) - [ATYR.US](https://longbridge.com/en/quote/ATYR.US.md) - [NIVF.US](https://longbridge.com/en/quote/NIVF.US.md) - [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md) - [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md) - [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [XHS.US](https://longbridge.com/en/quote/XHS.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [ATPC.US](https://longbridge.com/en/quote/ATPC.US.md) - [MAIA.US](https://longbridge.com/en/quote/MAIA.US.md) - [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md) - [BRTX.US](https://longbridge.com/en/quote/BRTX.US.md) - [JUNS.US](https://longbridge.com/en/quote/JUNS.US.md) - [QTEX.US](https://longbridge.com/en/quote/QTEX.US.md) - [ASBP.US](https://longbridge.com/en/quote/ASBP.US.md) - [NIVFW.US](https://longbridge.com/en/quote/NIVFW.US.md) - [ASBPW.US](https://longbridge.com/en/quote/ASBPW.US.md) ## Related News & Research - [aTyr Pharma expects FDA response by mid-September on efzofitimod Phase 3 sarcoidosis protocol](https://longbridge.com/en/news/297696098.md) - [Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 8,222 shares for $98,730.32](https://longbridge.com/en/news/297569079.md) - [Outlook Therapeutics posts CEO Bob Jahr “Why Now” investor conference webcast on demand](https://longbridge.com/en/news/297190965.md) - [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md) - [Grupa Azoty announces extraordinary shareholder meeting](https://longbridge.com/en/news/297635728.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**